Wird geladen...
Prospective Comparison of Three Enoxaparin Dosing Regimens to Achieve Target Anti-Factor Xa Levels in Hospitalized, Medically-Ill Patients with Extreme Obesity
Enoxaparin is commonly used to prevent venous thromboembolism (VTE) [1, 2] but has not been well-studied in patients with extreme obesity, a population at high risk for VTE. We prospectively compared three enoxaparin dosing regimens for the achievement of goal peak anti-Factor Xa levels in medically...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3385867/ https://ncbi.nlm.nih.gov/pubmed/22565589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23228 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|